Girum Hermeneut Enterprise researches, builds, and owns a portfolio of independent companies — each engineering original technology in its field, then translating it into real-world deployment through direct licensing partnerships.
Health, AI security, aerospace — and the ventures still to come — are each independent companies operating under one disciplined parent structure.
"We engineer original technology at the edge of what's currently possible, and build the operational discipline to carry it from research to real-world deployment — for partners who need infrastructure they can rely on."
Girum Hermeneut Enterprise operates as a parent holding company and R&D venture studio. Rather than building one product, we research and launch a portfolio of independent companies, each engineering its own core technology from first principles rather than adapting existing solutions.
Once a company's technology is validated, it's licensed directly to partners — health systems, enterprise and government technology teams, and aerospace and defense organizations — best positioned to deploy it at scale.
This is the beginning of the portfolio. Additional companies are already in development and will be announced as they launch.
The standards each venture inside the portfolio is built against.
We build from the underlying mathematics, biology, or systems architecture — not by adapting what already exists.
Each company runs its own team and roadmap, while sharing the parent enterprise's research and operational infrastructure.
We work directly with the institutions and organizations positioned to deploy each technology responsibly at scale.
Every venture is built for durability, not a single product cycle.
Each entity below is an independent company under Girum Hermeneut Enterprise.
Original approaches to oncology and public-health response.
A wholly-owned company developing a novel framework for identifying and targeting cancer cells and tumors, built on an original approach rather than adapting existing treatment methods. Also developing pandemic-response infrastructure for health system partners.
FocusBuilding AI systems resilient to data poisoning.
A wholly-owned company building an AI immunity framework against data poisoning attacks. In early prototype testing, injected poisoning attempts were successfully neutralized under conditions where unprotected models suffered significant performance degradation — results we're continuing to validate at scale.
FocusAutonomous aerospace platforms built on a distinct architecture.
A wholly-owned company originating a new class of autonomous robotics and drone systems, built around a distinct architecture rather than incremental upgrades to existing platforms. Early-stage research into propulsion and coordination systems.
FocusEvery company in the portfolio starts with a genuinely original approach in its field, then translates that research into a system built for real-world deployment.
Each company starts from first principles in its field, rather than adapting an existing method.
The research is engineered into a working framework: a model, a protocol, or a system architecture.
Each framework is tested and refined against real-world conditions before it's positioned for deployment.
Validated technology is licensed directly to the partners best positioned to deploy it responsibly.
For partnerships, licensing inquiries, press, or an early look at ventures still in development — reach the founder's office directly.
founder@girumhermeneut.com →